BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2017
View Archived Issues
Seattle Genetics and Immunomedics terminate license agreement for sacituzumab govitecan
Read More
Novo Nordisk reports key developments of first quarter 2017
Read More
Noninvasive panel of four markers can diagnose, monitor NASH
Read More
TherapeuticsMD receives complete response letter from FDA for TX-004HR as treatment of dyspareunia
Read More
Preclinical and interim phase I data for mRNA vaccine against H10N8 influenza virus
Read More
Uveitis candidate PP-001 displays ocular tolerability in vivo
Read More
Phase II results demonstrate IPV-Al vaccine is highly immunogenic in healthy infants
Read More
FDA grants fast track status to Axsome's AXS-05
Read More
Regeneron enters agreements with Inovio and SillaJen for combination studies of REGN-2810
Read More
Altimmune and PharmAthene complete merger
Read More
Durect enters Posimir development and commercialization agreement with Sandoz
Read More
Embera NeuroTherapeutics' EMB-001 well tolerated in phase Ib cocaine interaction study
Read More
FDA awards fast track status to Oncolytics Biotech's Reolysin for metastatic breast cancer
Read More
TLR8 agonism as a mechanism of action to treat chronic hepatitis B
Read More
Board recommends continuation of Fibrocell Science's phase I/II study of FCX-007
Read More
Elasmogen and Feldan announce research collaboration with Amgen
Read More
Novaliq announces successful application of first-in-class approach for treatment of dry eye disease
Read More
Exscientia and Sanofi enter agreement on bispecific small-molecule drugs for metabolic disease
Read More
Syros initiates phase I study of SY-1365 in advanced solid tumors
Read More
Polyphor discovers novel Pin1 inhibitors
Read More
Incyte describes new programmed cell death protein 1 inhibitors
Read More
